Results 1 to 10 of about 28,713 (267)

Circular RNA as a New Vaccine Platform: Considerations, Challenges, and Perspectives. [PDF]

Vaccines (Basel)
Lee KH, Lee J, Lee SW.
europepmc   +1 more source

The RNA-binding protein NOVA-1 regulates circRNA expression, alternative splicing, and aging in Caenorhabditis elegans. [PDF]

G3 (Bethesda)
Adeyemi E, Alshareef HZ, Bhat JM, Miura P, van der Linden AM.   +4 more
europepmc   +1 more source

Evaluation of the Association Between lncRNA-NEAT1 and CircRNA-UHRF1 Expression Levels in the Serum of SLE Patients. [PDF]

Appl Biochem Biotechnol
Marzouk RE, Mahdi L, Shaker OG, Gameil MA, Amrousy YM, El Kosaier MA, Abdelrahman R, Shawky NO, Kamel M.   +8 more
europepmc   +1 more source

Analysis of Factors Related to Lymph Node Metastasis Following Neoadjuvant Chemotherapy for Breast Cancer: Correlation Between Plasma Exosomal Circular RNA and Metastasis. [PDF]

Breast Cancer (Dove Med Press)
Ma S, Huang Y, Yang Q, Liu X, Zhang Z, Yan B.   +5 more
europepmc   +1 more source

A comprehensive landscape of the <i>Gossypium arboreum</i> circRNAome under multiple abiotic stresses. [PDF]

Front Plant Sci
Fei L, Zhou Y, Huang T, Wang K.
europepmc   +1 more source

The m6A-circRNA axis: a therapeutic prospect for gastric cancer. [PDF]

Cell Biol Toxicol
Li Z, Gu Y, Gu H, She QB, Tong Y.
europepmc   +1 more source

Evaluation of the circular RNA Pum1_0014, miRNA-146a, and miRNA-141-3p as biomarkers in PCOS. [PDF]

J Taibah Univ Med Sci
Abdel-Tawab MS, Ali HAA, Khalil EM, Atris WAA, Hassan ME, Reyad HR.   +5 more
europepmc   +1 more source

Identification of plasma exosome circRNA as potential novel biomarkers for DLBCL and circrna-miRNA-mRNA network analysis. [PDF]

Clin Exp Med
Cao Y, Guo L, Ge J, Qiu Y, Wang F, Li F, Gu W, Lin Y.   +7 more
europepmc   +1 more source

Circular RNAs: An Under-Recognized Part in Different Scenarios of Host-Parasite Interrelationships. [PDF]

Pathogens
Sharaf MS, Ashour DS, Othman AA.
europepmc   +1 more source

Transcriptional changes in the peripheral blood of at-risk individuals without clinical manifestation of Parkinson’s Disease

Whittle B, Chen C, Izuogu O, Jackson M, Santibanez-Koref M, Hudson G.   +5 more
europepmc   +1 more source